A new randomized trial put 12 mg of daily astaxanthin to the test in young male taekwondo athletes. After 28 days, the supplement group showed a significantly different creatine kinase trajectory than placebo, plus higher SOD and exploratory signs of lower MDA and less emotional and physical exhaustion. But the burnout findings were exploratory, with no group × time interaction on any subscale. The trial was small and measured biomarkers, not performance. Here's what the data show, what they don't, and who might want to pay attention.
This page is available in